Advertisement
New Zealand markets close in 5 hours 24 minutes
  • NZX 50

    11,785.11
    -50.93 (-0.43%)
     
  • NZD/USD

    0.5904
    -0.0002 (-0.04%)
     
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • OIL

    82.58
    -0.15 (-0.18%)
     
  • GOLD

    2,395.00
    -3.00 (-0.13%)
     

Examining Amgen’s Revenue Trend in Q2 2018

Examining Amgen’s Revenue Trend in Q2 2018

As we discussed earlier, Amgen (AMGN) reported a 4% rise in its year-over-year revenue to ~$6.06 billion in the second quarter compared to $5.81 billion in the first quarter of 2017. Amgen surpassed analysts’ estimates for EPS and revenue in the second quarter, reporting non-GAAP (generally accepted accounting principles) EPS of $3.83 on revenue of ~$6.1 billion compared to the estimate of $3.54 on revenue of $5.7 billion.